WO2017026923A1 - Stable cosmetic composition based on immobilized hyaluronidase and preparation method thereof - Google Patents
Stable cosmetic composition based on immobilized hyaluronidase and preparation method thereof Download PDFInfo
- Publication number
- WO2017026923A1 WO2017026923A1 PCT/RU2016/000532 RU2016000532W WO2017026923A1 WO 2017026923 A1 WO2017026923 A1 WO 2017026923A1 RU 2016000532 W RU2016000532 W RU 2016000532W WO 2017026923 A1 WO2017026923 A1 WO 2017026923A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hyaluronidase
- immobilized
- water
- cream
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/044—Suspensions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/982—Reproductive organs; Embryos, Eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the enzyme hyaluronidase is able to break down acidic
- mucopolysaccharides including hyaluronic acid.
- Patent RU 2286139 refers to face and body skin care products, and aimed at eliminating pustular rashes and cicatricial changes in the skin.
- the anti-acne cream contains a cosmetic base, eftederm, malavit, diclofenac, tincture of calendula, juniper oil, eucalyptus oil, cedar oil, tea tree oil, riboflavin (vitamin B2), lidase.
- U.S. Patent Application 20140328826 discloses a method for treating keloid scars, hypertrophic scars or scars by administering a composition comprising: low molecular weight hyaluronic acid, hyaluronidase, and optionally a pharmaceutically acceptable carrier and / or excipient.
- a serious obstacle to the penetration of high molecular weight compounds such as enzymes into the cell is the external
- cell membrane consisting of protein and lipid layers.
- the main problem in creating effective enzyme-based creams is to increase the stability of the protein molecule while maintaining its specific activity.
- the recognized most effective way to stabilize protein molecules and create prolonged proteins is immobilization (covalent conjugation) on high molecular weight carriers.
- the proposed cosmetic cream contains immobilized hyaluronidase, a substance belonging to the modern class of enzymatic preparations of prolonged action.
- the technological novelty of the cream lies in the use of immobilized hyaluronidase in which a polymer carrier, a derivative of polyethylene piperazine, belonging to a new class of water-soluble derivatives of heteroaliphatic aliphatic polyamines is used as a carrier and stabilizer of the enzyme.
- a polymer carrier is a polymer matrix that protects the protein molecule of the enzyme (active substance) from numerous body effects that lower specific activity.
- immobilized enzymes are artificially produced complexes or conjugates of an enzyme with a water-insoluble carrier.
- Immobilized hyaluronidase the substance has good solubility in water and in water-salt solutions, contribute to the retention of water in the composition, thereby improving the moisturizing properties of the cream.
- RU 2539390 01/20/2015 C1 discloses cosmetic compositions based on chondroitin sulfate, hyaluronidase, liposomes, beta-cyclodextrins, harpagophytum extract, ginger extract.
- a polymer carrier into the composition helps immobilize hyaluronidase and increase its activity.
- anti-scar effect there is no evidence of an anti-scar effect.
- the source RU 2471867 C2 which describes cosmetic compositions based on hyaluronidase, is described. Mentioned the possibility of creating funds against scars.
- Object of the invention the development of a new storage stable effective cosmetic product based on immobilized hyaluronidase.
- Any hyaluronidase covalently linked to the polymer carrier can be used.
- an immobilizing polymer any hyaluronidase covalently linked to the polymer carrier.
- polymers suitable for application to the skin are used, such as polyethylene glycol, hydroxyethyl starch,
- polyvinylpyrrolidone polysaccharides, silicones, etc. (e.g., polyvinylpyrrolidone, polysaccharides, silicones, etc. (e.g., polyvinylpyrrolidone, polysaccharides, silicones, etc. (e.g., polyvinylpyrrolidone, polysaccharides, silicones, etc. (e.g., polyvinylpyrrolidone, polysaccharides, silicones, etc. (e.g., etc.
- immobilized hyaluronidase is used in which the enzyme is covalently chemically bonded to the polymer support A-CO-NH-B, where A-CO is a fragment of the carboxyl function of the ⁇ -oxide derivative of poly-1,4-ethylene piperazine and B- ⁇ is the amino group of hyaluronidase and has hyaluronidase activity.
- a carboxyl-containing ⁇ -oxide derivative of poly-1,4-ethylene piperazine with a molecular weight of 20,000 to 40,000 Da can be used.
- the hydrazide method involves the azidation reaction of a hydrazide derivative of a carboxyalkyl substituted--oxide of poly-1,4-ethylene piperazine (PEP) in the presence of sodium nitrite, followed by a conjugation reaction of the activated PEP derivative with hyaluronidase.
- the immobilized hyaluronidase is purified by ultrafiltration on a membrane cassette with a lower cut-off limit of 5 kDa, followed by freeze drying of the purified solution of the preparation.
- the carbodiimide method involves the conjugation of hyaluronidase with a carboxyalkyl-substituted--oxide of poly-1,4-ethylene piperazine in the presence of a condensing agent of water-soluble carbodiimide, followed by purification by ultrafiltration on a membrane cassette with a lower cut-off limit of 5 kDa particles and freeze drying.
- the source of hyaluronidase can be bovine or sheep testes.
- LILO DERM 4/1 (LIPODERM 4/1) is a self-emulsifying cream base with pronounced emollient and water-retaining properties, intended for the manufacture of cosmetic and pharmaceutical creams and oil-in-water emulsions of various consistencies.
- Composition Lipoderm 4/1: glycerol monostearate, stearic alcohol, cetyl alcohol, diethylene glycol stearate, PEG-400 stearate, Polysorbate 20, PEG-40 hydrogenated castor oil, dipropylene glycol.
- the selected foundation determines the effective softening of the skin, increasing its elasticity, activating the processes of cell renewal, smoothing small wrinkles. It has been unexpectedly discovered that this base significantly increases the effectiveness of hyaluronidase.
- any flavoring acceptable in cosmetic products can be used to give a pleasant smell. It can be either a substance that gives both a monoaromat (for example, apricot, orange, lemon, banana), and a bouquet of aromas (for example, “chocolate surprise”, “Iris cream”).
- a monoaromat for example, apricot, orange, lemon, banana
- a bouquet of aromas for example, “chocolate surprise”, “Iris cream”.
- the proposed cream based on immobilized hyaluronidase has the following preferred applications: - Prevention of scar formation after cosmetic procedures, tattoo removal, laser resurfacing of the skin, dermabrasion, mid and deep exfoliations, hair removal;
- Example 3 A study of the effectiveness of a cream to prevent scarring after cosmetic procedures.
- Group 1-cream according to example 2 without immobilization of hyaluronidase Group 2 - cream according to example 2 with immobilized hyaluronidase and a base made of a polyethylene oxide gel (should I give an example with a gel.
- the cream according to the invention restores the normal color of the skin and normalizes the hydration of scar tissue.
- the proposed cream can prevent the formation of scars and scars, make them almost invisible, more elastic, and also relieve itching and pain in the first days of applying the cream.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Cosmetics (AREA)
Abstract
Description
Стабильная косметическая композиция на основе Stable cosmetic composition based on
иммобилизованной гиалуронидазы и способ ее получения immobilized hyaluronidase and method thereof
Изобретение относится к области косметологии и касается The invention relates to the field of cosmetology and relates to
косметических средств на основе фермента гиалуронидазы. cosmetics based on the enzyme hyaluronidase.
Фермент гиалуронидаза способен расщеплять кислые The enzyme hyaluronidase is able to break down acidic
мукополисахариды, в том числе гиалуроновую кислоту. Процесс mucopolysaccharides, including hyaluronic acid. Process
деполимеризации последней до свободных гексоз повышает тканевую и сосудистую проницаемость, что может найти применение при нарушениях и косметических дефектах, сопровождающихся ростом соединительной ткани. Известны различные источники, касающиеся использования гиалуронидазы для устранения подобных дефектов. depolymerization of the latter to free hexoses increases tissue and vascular permeability, which can be used for disorders and cosmetic defects accompanied by growth of connective tissue. Various sources are known regarding the use of hyaluronidase to eliminate such defects.
Патент RU 2286139, 27.10.2006 относится к средствам для ухода за кожей лица и тела, и направленным на устранение гнойничковых высыпаний и рубцовых изменений кожи. Крем противоугревой содержит косметическую основу, эфтидерм, малавит, диклофенак, настойку календулы, можжевеловое масло, масло эвкалипта, кедровое масло, масло чайного дерева, рибофлавин (витамин В2), лидазу. Patent RU 2286139, 10.27.2006, refers to face and body skin care products, and aimed at eliminating pustular rashes and cicatricial changes in the skin. The anti-acne cream contains a cosmetic base, eftederm, malavit, diclofenac, tincture of calendula, juniper oil, eucalyptus oil, cedar oil, tea tree oil, riboflavin (vitamin B2), lidase.
Патентная заявка США 20140328826 раскрывает способ лечения келоидных рубцов, гипертрофических рубцов или шрамов путем введения композиции, содержащей: низкомолекулярную гиалуроновую кислоту, гиалуронидазу, и, необязательно, фармацевтически приемлемый носитель и / или наполнитель. Однако серьезным препятствием для проникновения внутрь клетки таких высокомолекулярных соединений, как ферменты, является наружная U.S. Patent Application 20140328826 discloses a method for treating keloid scars, hypertrophic scars or scars by administering a composition comprising: low molecular weight hyaluronic acid, hyaluronidase, and optionally a pharmaceutically acceptable carrier and / or excipient. However, a serious obstacle to the penetration of high molecular weight compounds such as enzymes into the cell is the external
клеточная мембрана, состоящая из белкового и липидного слоев. cell membrane consisting of protein and lipid layers.
Решить эти проблемы помогает создание иммобилизованных ферментов. The creation of immobilized enzymes helps to solve these problems.
Основной проблемой при создании эффективных кремов на основе ферментов является повышение стабильности белковой молекулы при сохранении ее специфической активности. Признанным наиболее эффективным способом стабилизации белковых молекул и создания пролонгированных белков является иммобилизация (ковалентная конъюгация) на высокомолекулярных носителях. The main problem in creating effective enzyme-based creams is to increase the stability of the protein molecule while maintaining its specific activity. The recognized most effective way to stabilize protein molecules and create prolonged proteins is immobilization (covalent conjugation) on high molecular weight carriers.
Предлагаемый косметический крем содержит в своем составе иммобилизованную гиалуронидазу, вещество относящиеся к современному классу ферментативных препаратов пролонгированного действия. Технологическая новизна крема заключается в использовании иммобилизованной гиалуронидазы в которой в качестве носителя и стабилизатора фермента используются полимерный носитель, производный полиэтиленпиперазина, относящийся к новому классу водорастворимых производных гетероцепных алифатических полиаминов. The proposed cosmetic cream contains immobilized hyaluronidase, a substance belonging to the modern class of enzymatic preparations of prolonged action. The technological novelty of the cream lies in the use of immobilized hyaluronidase in which a polymer carrier, a derivative of polyethylene piperazine, belonging to a new class of water-soluble derivatives of heteroaliphatic aliphatic polyamines is used as a carrier and stabilizer of the enzyme.
Полимерный носитель является полимерной матрицей, которая защищает белковую молекулу фермента (действующее вещество) от многочисленных воздействий организма, понижающих специфическую активность. A polymer carrier is a polymer matrix that protects the protein molecule of the enzyme (active substance) from numerous body effects that lower specific activity.
Обычно иммобилизованные ферменты— это искусственно полученные комплексы или конъюгаты фермента с нерастворимым в воде носителем. Иммобилизованная гиалуронидаза, вещество имеет хорошую растворимость в воде и в водно-солевых растворах, способствуют удерживанию воды в композиции, тем самым улучшая увлажняющие свойства крема. Typically, immobilized enzymes are artificially produced complexes or conjugates of an enzyme with a water-insoluble carrier. Immobilized hyaluronidase, the substance has good solubility in water and in water-salt solutions, contribute to the retention of water in the composition, thereby improving the moisturizing properties of the cream.
-Известны косметические композиции, содержащие иммобилизованные ферменты (липолитические липазы, протеазы и протеолитические ферменты для расщепления гликопротеинов в коже и высвобождением олигосахаридов) для местного применения (US4556554 (А)— 1985-12-03). Нет конкреного упоминания гиалуронидазы и ее назначения. - Known cosmetic compositions containing immobilized enzymes (lipolytic lipases, proteases and proteolytic enzymes for the breakdown of glycoproteins in the skin and release oligosaccharides) for local use (US4556554 (A) - 1985-12-03). There is no concrete mention of hyaluronidase and its purpose.
RU 2539390 20.01.2015 С1 раскрывает косметические композиции, на основе хондроитин сульфата, гиалуронидазы, липосом, бета- циклодекстринов, экстракта гарпагофитума, экстракта имбиря. В описании к источнику отмечается, что введение в состав композиции полимерного носителя способствует иммобилизации гиалуронидазы и повышению ее активности. Однако отсутствуют какие-либо данные о противорубцовом эффекте. Данные композиции разработаны для нанесения на область суставов. RU 2539390 01/20/2015 C1 discloses cosmetic compositions based on chondroitin sulfate, hyaluronidase, liposomes, beta-cyclodextrins, harpagophytum extract, ginger extract. In the description of the source, it is noted that the introduction of a polymer carrier into the composition helps immobilize hyaluronidase and increase its activity. However, there is no evidence of an anti-scar effect. These compositions are designed to be applied to the joint area.
В качестве ближайшего аналога может быть указан источник RU 2471867 С2, в котором описаны косметические композиции на основе гиалуронидазы. Упомянута возможность создания средств против рубцов. As the closest analogue, the source RU 2471867 C2, which describes cosmetic compositions based on hyaluronidase, is described. Mentioned the possibility of creating funds against scars.
Задача изобретения: разработка нового стабильного при хранении эффективного косметического средства на основе иммобилизованной гиалуронидазы. Object of the invention: the development of a new storage stable effective cosmetic product based on immobilized hyaluronidase.
Задача решается косметическим кремом, содержащим The problem is solved by a cosmetic cream containing
иммобилизованную гиалуронидазу, ковалентно связанную с активным полимерным носителем, косметическую основу, состоящую из липодерма 4/1 и воды, консервант натрия бензоат при следующих соотношениях immobilized hyaluronidase covalently bound to an active polymer carrier, a cosmetic base consisting of 4/1 lipoderm and water, a sodium benzoate preservative in the following ratios
компонентов, масс. %: липодерм - 10-20 иммобилизованная гиалуронидаза - 0,2-0,6 натрия бензоат - 0,05 - 0,1 ароматизатор - до 0,3 з вода дистиллированная - остальное. components, mass. %: lipoderm - 10-20 immobilized hyaluronidase - 0.2-0.6 sodium benzoate - 0.05 - 0.1 flavoring - up to 0.3 s distilled water - the rest.
Может быть использована любая ковалентно связанная с полимерным носителем гиалуронидаза. В качестве иммобилизующего полимера, Any hyaluronidase covalently linked to the polymer carrier can be used. As an immobilizing polymer,
например, используют различные приемлемые для нанесения на кожу полимеры, такие как полиэтиленгликоль, гидроксиэтилкрахмал, for example, various polymers suitable for application to the skin are used, such as polyethylene glycol, hydroxyethyl starch,
поливинилпирролидон, полисахариды, силиконы и др. (например polyvinylpyrrolidone, polysaccharides, silicones, etc. (e.g.
полученные по способам, описанным в WO2010021570, US 7521434, RU 2409669, http ://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563746/)· obtained by the methods described in WO2010021570, US 7521434, RU 2409669, http: //www.ncbi.nlm.nih.gov/pmc/articles/PMC3563746/) ·
Предпочтительно используют иммобилизованную гиалуронидазу, в которой фермент связан ковалентной химической связью с полимерным носителем A-CO-NH-Б, где А-СО -фрагмент карбоксильной функции производного Ν-оксида поли-1,4-этиленпиперазина, а Б-ΝΗ- аминогруппа гиалуронидазы и обладает гиалуронидазной активностью. Preferably, immobilized hyaluronidase is used in which the enzyme is covalently chemically bonded to the polymer support A-CO-NH-B, where A-CO is a fragment of the carboxyl function of the Ν-oxide derivative of poly-1,4-ethylene piperazine and B-ΝΗ is the amino group of hyaluronidase and has hyaluronidase activity.
В качестве носителя может быть использовано карбоксилсодержащее производное Ν-оксида поли-1,4-этиленпиперазина с молекулярной массой 20 000 - 40000 Да. As the carrier, a carboxyl-containing Ν-oxide derivative of poly-1,4-ethylene piperazine with a molecular weight of 20,000 to 40,000 Da can be used.
-Иммобилизация гиалуронидазы с карбоксилсодержащим производном Ν-оксида поли-1,4-этиленпиперазина осуществляется карбодиимидным или гидразидным методами в водых растворах. - Immobilization of hyaluronidase with a carboxyl-containing derivative of Ν-oxide poly-1,4-ethylene piperazine is carried out by carbodiimide or hydrazide methods in aqueous solutions.
Гидразидный метод включает реакцию азидирования гидразидного производного карбоксиалкилзамещенного Ν-оксида поли- 1,4- этиленпиперазина (ПЭП) в присутствии нитрита натрия с последующей реакцией конъюгации активированного производного ПЭП с гиалуронидазой. Очистка иммобилизованной гиалуронидазы осуществляется ультрафильтрацией на кассете с мембранами с нижним пределом отсекания частиц 5 кДа с последующим лиофильным высушиванием очищенного раствора препарата. Карбодиимидный метод включает реакцию конъюгации гиалуронидазы с карбоксиалкилзамещенным Ν-оксидом поли-1,4-этиленпиперазина в присутствии конденсирующего агента водорастворимого карбодиимида с последующей очисткой ультрафильтрацией на кассете с мембранами с нижним пределом отсекания частиц 5 кДа и лиофильным высушиванием. The hydrazide method involves the azidation reaction of a hydrazide derivative of a carboxyalkyl substituted--oxide of poly-1,4-ethylene piperazine (PEP) in the presence of sodium nitrite, followed by a conjugation reaction of the activated PEP derivative with hyaluronidase. The immobilized hyaluronidase is purified by ultrafiltration on a membrane cassette with a lower cut-off limit of 5 kDa, followed by freeze drying of the purified solution of the preparation. The carbodiimide method involves the conjugation of hyaluronidase with a carboxyalkyl-substituted--oxide of poly-1,4-ethylene piperazine in the presence of a condensing agent of water-soluble carbodiimide, followed by purification by ultrafiltration on a membrane cassette with a lower cut-off limit of 5 kDa particles and freeze drying.
Источником гиалуронидазы могут быть бычьи или овечьи семенники. The source of hyaluronidase can be bovine or sheep testes.
В качестве основы предложено использовать липодерм 4/1. ЛИЛО ДЕРМ 4/1 (LIPODERM 4/1) - самоэмульгирующая кремовая основа с выраженными смягчающими и влагоудерживающими свойствами, предназначенная для изготовления косметических и фармацевтических кремов и эмульсий типа "масло-в-воде" различной консистенции. Состав Липодерм 4/1 : моностеарат глицерина, стеариновый спирт, цетиловый спирт, стеарат диэтиленгликоля, стеарат ПЭГ-400, полисорбат 20, ПЭГ-40 гидрогенизированное касторовое масло, дипропиленгликоль. Выбранная основа обуславливает эффективное смягчение кожи, повышение ее эластичности, активизацию процессов обновления клеток, разглаживание мелких морщин. Неожиданно было обнаружено, что данная основа значительно увеличивает эффективность гиалуронидазы. As a basis, it is proposed to use lipoderm 4/1. LILO DERM 4/1 (LIPODERM 4/1) is a self-emulsifying cream base with pronounced emollient and water-retaining properties, intended for the manufacture of cosmetic and pharmaceutical creams and oil-in-water emulsions of various consistencies. Composition Lipoderm 4/1: glycerol monostearate, stearic alcohol, cetyl alcohol, diethylene glycol stearate, PEG-400 stearate, Polysorbate 20, PEG-40 hydrogenated castor oil, dipropylene glycol. The selected foundation determines the effective softening of the skin, increasing its elasticity, activating the processes of cell renewal, smoothing small wrinkles. It has been unexpectedly discovered that this base significantly increases the effectiveness of hyaluronidase.
В качестве ароматизатора может быть использован любой приемлемый в косметических изделиях ароматизатор, придающий приятный запах. Это может быть как вещество, придающее как моноаромат (например, абрикос, апельсин, лимон, банан ), так и букет ароматов (например, "шоколадный сюрприз" , "Ирисо-сливочный" ) . As a flavoring, any flavoring acceptable in cosmetic products can be used to give a pleasant smell. It can be either a substance that gives both a monoaromat (for example, apricot, orange, lemon, banana), and a bouquet of aromas (for example, “chocolate surprise”, “Iris cream”).
Предложенный крем на основе иммобилизованной гиалуронидазы имеет следующие предпочтительные области применения: - Профилактика формирования рубцов после косметических процедур, удаления татуировок, лазерных шлифовок кожи, дермабразии, срединных и глубоких пилингов, эпиляций; The proposed cream based on immobilized hyaluronidase has the following preferred applications: - Prevention of scar formation after cosmetic procedures, tattoo removal, laser resurfacing of the skin, dermabrasion, mid and deep exfoliations, hair removal;
- Последствия угревой болезни; - The consequences of acne;
- Дефекты ногтевой пластинки, вызванные заболеваниями негрибковой этиологии; - Defects in the nail plate caused by diseases of non-fungal etiology;
- Рубцы после фотодинамических процедур, ожогов, в том числе солнечных. - Scars after photodynamic procedures, burns, including sunburn.
- Свежие и зрелые рубцы: посттравматические, послеожоговые и послеоперационные рубцы. - Fresh and mature scars: post-traumatic, post-burn and postoperative scars.
Технический результат: высокая эффективность, устранение или значительное уменьшение интенсивности окраски рубцового поражения по сравнению с окружающими тканями. Effect: high efficiency, elimination or a significant decrease in the color intensity of cicatricial lesions compared with surrounding tissues.
Технология производства: Production technology:
1. Нагреть водную и жирную фазу (липодерм 4/1) раздельно до 80-85 С 1. Heat the aqueous and oily phase (lipoderm 4/1) separately to 80-85 C
2. Перемешивать 2-5 минут при Т=80-85°С, затем охладить до Т=60-65°С и перемешать до однородного состояния 2. Stir for 2-5 minutes at T = 80-85 ° C, then cool to T = 60-65 ° C and mix until smooth
3. При перемешивании довести эмульсию до Т=32-35°С и ввести заранее растворённую в воде активную субстанцию (иммобилизованная 3. With stirring, bring the emulsion to T = 32-35 ° C and introduce the active substance previously dissolved in water (immobilized
гиалуронидаза) и растворённый в воде консервант (натрия бензоат) hyaluronidase) and a preservative dissolved in water (sodium benzoate)
4. Продолжить перемешивание до достижения комнатной температуры эмульсии. 4. Continue mixing until the emulsion reaches room temperature.
Возможность осуществления изобретения может быть The possibility of carrying out the invention may be
продемонстрирована нижеследующими примерами. demonstrated by the following examples.
б Пример 1 липодерм - 20 иммобилизованная гиалуронидаза - 0,4 натрия бензоат 0,05 ароматизатор «Абрикос»- 0,1 вода дистиллированная - до 100%. Пример 2 липодерм - 10 иммобилизованная гиалуронидаза - 0,6 натрия бензоат - 0,1 - вода дистиллированная - до 100%. b Example 1 lipoderm - 20 immobilized hyaluronidase - 0.4 sodium benzoate 0.05 Apricot flavoring - 0.1 distilled water - up to 100%. Example 2 lipoderm - 10 immobilized hyaluronidase - 0.6 sodium benzoate - 0.1 - distilled water - up to 100%.
Пример 3 Исследование эффективности крема для предупреждения возникновения рубцов после косметических процедур. Example 3 A study of the effectiveness of a cream to prevent scarring after cosmetic procedures.
Были сформированы три группы пациентов после удаления татуировок, проведения лазерной шлифовки кожи, глубокого пилинга, а также после эпиляций. Группа 1 -крем по примеру 2 без иммобилизации гиалуронидазы. Группа 2- крем по примеру 2 с иммобилизованной гиалуронидазой и основой из геля полиэтиленоксида (нужно ли приводить пример с гелем . Группа 3- крем по примеру 2. Three groups of patients were formed after tattoo removal, laser resurfacing of the skin, deep peeling, and also after hair removal. Group 1-cream according to example 2 without immobilization of hyaluronidase. Group 2 - cream according to example 2 with immobilized hyaluronidase and a base made of a polyethylene oxide gel (should I give an example with a gel. Group 3 - cream according to example 2.
Пациенты наносили крема два раза в сутки, комплаентность (соблюдение указаний врача-косметолога) в группах составила примерно от 85 до 88% пациентов. Крем легко наносился и оставался на коже в течение многих часов. В исследовании практически не было отмечено побочных эффектов, связанных с применением крема. Patients applied the cream twice a day, compliance (following the instructions of the cosmetologist) in the groups ranged from about 85 to 88% of patients. The cream was easy to apply and stayed on the skin for many hours. In the study, there were practically no side effects associated with the use of the cream.
Образование рубцов наблюдали у 94% процентов пациентов группы 1, 87%- у группы 2. При этом рубцы в группе крема отмечались только в 26% случаев и были гораздо меньше, чем в контрольной группе. Заключительная оценка в конце третьего месяца показала, что разница между двумя группами контроля и третьей группой была статистически значима. Scarring was observed in 94% of patients in group 1, 87% in group 2. Moreover, scars in the cream group were observed only in 26% of cases and were much less than in the control group. A final evaluation at the end of the third month showed that the difference between the two control groups and the third group was statistically significant.
Было отмечено, что крем по изобретению восстанавливает нормальную окраску кожи и нормализует гидратацию рубцовой ткани. При It was noted that the cream according to the invention restores the normal color of the skin and normalizes the hydration of scar tissue. At
использовании других основ вместо липодерма цвет в области поражения отличался. using other substrates instead of lipoderm, the color in the affected area was different.
Предложенный крем позволяет предупредить образование рубцов и шрамов, сделать их практически малозаметными, более эластичными, а также снять зуд и боль уже в первые дни применения крема. The proposed cream can prevent the formation of scars and scars, make them almost invisible, more elastic, and also relieve itching and pain in the first days of applying the cream.
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2015133579/15A RU2604160C1 (en) | 2015-08-11 | 2015-08-11 | Stable cosmetic composition based on immobilized hyaluronidase and preparation method thereof |
| RU2015133579 | 2015-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2017026923A1 true WO2017026923A1 (en) | 2017-02-16 |
Family
ID=57776695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/RU2016/000532 Ceased WO2017026923A1 (en) | 2015-08-11 | 2016-08-10 | Stable cosmetic composition based on immobilized hyaluronidase and preparation method thereof |
Country Status (3)
| Country | Link |
|---|---|
| EA (1) | EA030842B1 (en) |
| RU (1) | RU2604160C1 (en) |
| WO (1) | WO2017026923A1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2027427C1 (en) * | 1990-07-10 | 1995-01-27 | Агрофирма "Стальгене" | Tone cream |
| RU2314093C2 (en) * | 2006-03-02 | 2008-01-10 | Общество с Ограниченной Ответственностью "Скимед" | Curative-cosmetic agent |
| RU2371172C2 (en) * | 2007-11-07 | 2009-10-27 | Закрытое акционерное общество "Биологические исследования и системы" | Stephaglabrin-based pharmaceutical composition of local and external application for treatment of traumatic and post-operation injury of peripheral nervous system |
| RU2471867C2 (en) * | 2007-06-19 | 2013-01-10 | Тамара П. Уваркина | Hyaluronidase and method for using it |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2214226C2 (en) * | 2000-09-18 | 2003-10-20 | Бурангулов Наиль Идрисович | Cosmetic cream |
| US20100098794A1 (en) * | 2008-10-17 | 2010-04-22 | Armand Gerard | Topical anti-wrinkle and anti-aging moisturizing cream |
| RU2421239C1 (en) * | 2009-10-19 | 2011-06-20 | Общество С Ограниченной Ответственностью "Саентифик Фьючер Менеджмент" | Agent intensifying action of biologically active substances and drugs |
| WO2012070971A1 (en) * | 2010-11-22 | 2012-05-31 | Farber Boris Slavinovich | Cosmetic and pharmaceutical composition for rejuvenating and regenerating the skin, inter alia after surgical operations |
-
2015
- 2015-08-11 RU RU2015133579/15A patent/RU2604160C1/en active
-
2016
- 2016-07-29 EA EA201600510A patent/EA030842B1/en unknown
- 2016-08-10 WO PCT/RU2016/000532 patent/WO2017026923A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2027427C1 (en) * | 1990-07-10 | 1995-01-27 | Агрофирма "Стальгене" | Tone cream |
| RU2314093C2 (en) * | 2006-03-02 | 2008-01-10 | Общество с Ограниченной Ответственностью "Скимед" | Curative-cosmetic agent |
| RU2471867C2 (en) * | 2007-06-19 | 2013-01-10 | Тамара П. Уваркина | Hyaluronidase and method for using it |
| RU2371172C2 (en) * | 2007-11-07 | 2009-10-27 | Закрытое акционерное общество "Биологические исследования и системы" | Stephaglabrin-based pharmaceutical composition of local and external application for treatment of traumatic and post-operation injury of peripheral nervous system |
Non-Patent Citations (2)
| Title |
|---|
| "Instruktsiia po meditsinskomu primeneniiu preparata Longidaza", LSR-002940/07-011007, 1 October 2007 (2007-10-01), pages 1 * |
| FRIDMAN R. A.: "«Tekhnologiia kosmetiki»", 2-E IZDANIE PERERABOTANNOE I DOPOLNENNOE, M., IZD-VO «PISHCHEVAIA PROMYSHLENNOST», 1984, pages 224 - 225 , 236-241 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EA030842B1 (en) | 2018-10-31 |
| EA201600510A1 (en) | 2017-02-28 |
| RU2604160C1 (en) | 2016-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schafer et al. | Natural ingredients of transdermal drug delivery systems as permeation enhancers of active substances through the stratum corneum | |
| US7838011B2 (en) | Stabilized protein compositions for topical administration and methods of making same | |
| US7727537B2 (en) | Stabilized compositions for topical administration and methods of making same | |
| JP5848260B2 (en) | Stabilized protease for use in skin care | |
| JP6175488B2 (en) | Exopolysaccharides for the treatment and / or care of skin, mucous membranes and / or nails | |
| KR20040006007A (en) | Acidic composition for external use and agent for accelerating infiltration of cosmetic preparation, hair-growing agent, and preparation for external use each containing the composition into skin or the like | |
| KR20150135425A (en) | Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails | |
| KR20150128481A (en) | Composition for application of skin comprising of extracellular matrix and thermo sensitive macromolecule | |
| RS63786B1 (en) | STEM CELL STIMULATION COMPOSITIONS AND MELASMA TREATMENT PROCEDURES | |
| EP1853303B1 (en) | Stabilized compositions for topical administration and methods of making same | |
| Rejinold et al. | Chitosan hybrids for cosmeceutical applications in skin, hair and dental care: an update | |
| KR102737831B1 (en) | Cosmetic composition for improving skin wrinkles containing exosomes | |
| JP2000273033A (en) | Gel comprising natural material | |
| CA2494473C (en) | Stabilized protein compositions for topical administration and methods of making same | |
| US20150283080A1 (en) | Stabilized dermatological delivery system for active ingredient compositions for topical administration to the skin | |
| EP1684681A1 (en) | Transdermal high and low molecular weight compounds | |
| RU2604160C1 (en) | Stable cosmetic composition based on immobilized hyaluronidase and preparation method thereof | |
| JPS5869806A (en) | Cosmetic lotion containing stable collagen | |
| JP2008179551A (en) | Transdermal absorption preparation | |
| WO2015181746A1 (en) | Gel form of a heparin sodium salt for dermal administration, and a method for its preparation. | |
| CA3099843A1 (en) | Sterile topical saline putrescine formulation and uses thereof | |
| Tansathien et al. | Investigation of lipid nanocarriers and microspicule gel for dermal delivery of porcine placenta extract | |
| JPH11116458A (en) | Skin external preparation composition | |
| CN117295486A (en) | Cosmetic for skin penetration of hyaluronate | |
| KR102849236B1 (en) | Cosmetic composition for skin regeneration comprising exosome, pdrn and pn composition and method of preparing thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16835533 Country of ref document: EP Kind code of ref document: A1 |
|
| DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 16835533 Country of ref document: EP Kind code of ref document: A1 |